Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
Astragaloside IV Protects Hearts from Sepsis Through Mitochondrial Quality ControlLongevity & Aging

Astragaloside IV Protects Hearts from Sepsis Through Mitochondrial Quality Control

Researchers discovered that Astragaloside IV, a compound from traditional Chinese medicine, protects the heart during sepsis by regulating mitochondrial quality control through the DUSP1-PHB2 pathway. Using genetically modified mice and cell studies, they found this compound normalizes mitochondrial function, reduces inflammation, and preserves cardiac structure during septic cardiomyopathy - a serious complication affecting heart function in severe infections.

Deep Dive Audio
0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.